<DOC>
	<DOCNO>NCT00204022</DOCNO>
	<brief_summary>The purpose study determine whether mycophenolate mofetil superior azathioprine prevent flare lupus nephritis .</brief_summary>
	<brief_title>Mycophenolate Mofetil Versus Azathioprine Maintenance Therapy Lupus Nephritis .</brief_title>
	<detailed_description>Proliferative glomerulonephritis common severe manifestation systemic lupus erythematosus ( SLE ) usually require intensive therapy high dos glucocorticosteroids cytotoxic drug , intravenous ( IV ) cyclophosphamide ( CYC ) . The objective MAINTAIN Nephritis Trial compare mycophenolate mofetil ( MMF ) azathioprine ( AZA ) , term efficacy toxicity , remission-maintaining treatment proliferative lupus glomerulonephritis , remission-inducing therapy short-course IV CYC regimen . The hypothesis address MAINTAIN Nephritis Trial MMF superior AZA .</detailed_description>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>SLE age ≥ 14 year Proteinuria ≥ 500 mg/day Biopsyproven proliferative lupus nephritis Recent treatment highdose glucocorticoid Recent treatment immunosuppressive drug More exclusion criterion protocol</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Lupus nephritis</keyword>
	<keyword>Treatment</keyword>
	<keyword>Maintenance therapy</keyword>
	<keyword>Mycophenolate mofetil</keyword>
	<keyword>Azathioprine</keyword>
</DOC>